Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor.
about
Congenital neutropenia: diagnosis, molecular bases and patient management.Granulocyte-colony stimulating factor for hematopoietic stem cell donation from healthy female donors during pregnancy and lactation: what do we know?The investigation and management of chronic neutropenia in children.Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia.Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering.Relapsing acute kidney injury associated with pegfilgrastim.Both systemic and local application of granulocyte-colony stimulating factor (G-CSF) is neuroprotective after retinal ganglion cell axotomy.Pathophysiologic mechanisms, clinical features and treatment of idiopathic neutropenia.Side effects of cytokines approved for therapy.Management and controversies of classical Hodgkin lymphoma in pregnancy.Modern management of phagocyte defects.Expression of granulocyte colony stimulating factor and its receptor by retinal pigment epithelial cells: a role in maintaining differentiation-competent state.Leukocytoclastic vasculitis as a complication of recombinant granulocyte colony-stimulating factor therapy in a heart transplant patient.Application of whole-exome sequencing to unravel the molecular basis of undiagnosed syndromic congenital neutropenia with intellectual disability.
P2860
Q33395402-5C6F9080-E745-46B7-A5BF-2B6FB50BA110Q34320722-7661B568-961B-4585-A023-E5A602DD4155Q34567825-16131AFE-1F63-4E7D-8F50-961A9C6E8C24Q34857809-050CC288-E4A8-4497-A15B-CC0D333886CAQ36428933-5DCE55AB-7231-4B66-9B53-4D86AD365A09Q36526060-C39A48C8-20D7-4041-BCF7-20629215AB57Q37214453-DC2B0567-5740-409D-A522-BB20343553E3Q37810067-DA4A0A2C-044A-43BA-B973-BB69045B83F2Q38255698-3E8D83D2-4100-42F3-A698-CA2E864D9A52Q38356460-C6C08434-F8E2-4EBD-B50B-C6EF9A2D0B58Q38950276-D0883873-0D3D-489D-A622-340F5B26D41AQ39570530-7F3E7DE2-B6FF-4D0F-9C00-6F23817947C7Q41959384-9B3639BB-B3B0-4CB3-B2A0-CF502734F2EFQ53716635-C18F353D-E3E8-46F9-A733-065B38063354
P2860
Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Risk and benefit of treatment ...... yte colony-stimulating factor.
@ast
Risk and benefit of treatment ...... yte colony-stimulating factor.
@en
type
label
Risk and benefit of treatment ...... yte colony-stimulating factor.
@ast
Risk and benefit of treatment ...... yte colony-stimulating factor.
@en
prefLabel
Risk and benefit of treatment ...... yte colony-stimulating factor.
@ast
Risk and benefit of treatment ...... yte colony-stimulating factor.
@en
P2093
P356
P1476
Risk and benefit of treatment ...... yte colony-stimulating factor.
@en
P2093
Carol J Fier
Jean Donadieu
Sally E Kinsey
Tammy E Cottle
P304
P356
10.1053/SHEM.2002.31914
P577
2002-04-01T00:00:00Z